A prospective, non-randomised, single arm observational study to access the safety and effectiveness of Siddha Sastric Medicines â?? Fixed Regimen intervention in prevention of COVID-19 disease progression of severity from COVID-19 Positive asymptomatic, mild or moderate to critical with reference to the Siddha guidelines of COVID-19 management, Ministry of AYUSH, Govt. of India at a Home Quarantine Chennai Containment Zone

Almaa Siddha Multispeciality Hospital Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. COVID -19 Positive as determined by RT-PCR or other approved commercial or public health assay
•2. Willing to provide written/digital informed consent.
•3.COVID - 19 Positive with no clinical signs
•4.COVID - 19 Positive with mild symptoms â?? Sneezing, Cough, Sore Throat, Throat Pain, Malaise, Tiredness, Fever
•5.COVID - 19 Positive with moderate symptoms â?? Fever with cough, breathlessness but respiratory rate <24 per minute and Oxygen saturation more than 94% at rest

•1. Pregnant and Lactating females
•2. COVID - 19 Positive with Severe symptoms â?? Respiratory distress ( >24 breath per minute), Oxygen saturation less than 94% at rest, Respiratory failure, Need of Mechanical Ventilation, Septic shock, Non respiratory organ failure
•3. Chronic Renal Failure requiring dialysis (eGFR < 30)
•4. Known cases of uncontrolled Diabetes ( >9% HbA1c)
•5. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening
•6. Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc.
•7. Subjects taking Steroid treatment and or any kind of immunosuppressive therapy
•8. Subjects participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study.
•9. Subjects having a past history of allergy to any medicine that is part of the Siddha intervention.
•10. Subjects with bleeding disorders and severe anaemia(Hb - <7 g/dL)

发起方

Almaa Siddha Multispeciality Hospital Pvt Ltd